Evaluation of a commercial probe assay for detection of rifampin resistance inMycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples
- 1 March 1998
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 17 (3) , 189-192
- https://doi.org/10.1007/bf01691116
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mapping and sequencing of mutations in the Escherichia colirpoB gene that lead to rifampicin resistancePublished by Elsevier ,2004
- Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assayTubercle and Lung Disease, 1995
- Characterization of rifampin-resistance in pathogenic mycobacteriaAntimicrobial Agents and Chemotherapy, 1994
- Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysisAntimicrobial Agents and Chemotherapy, 1993
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993
- Nosocomial Transmission of Multidrug-resistant Mycobacterium tuberculosisAnnals of Internal Medicine, 1992
- Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant BacilliAnnals of Internal Medicine, 1992
- Drug susceptibility testing in tuberculosis: A comparison of the proportion methods using Lowenstein-Jensen, middlebrook 7H10 and 7H11 agar media and a radiometric methodResearch in Microbiology, 1989
- Qualitative and Quantitative Drug-susceptibility Tests in MycobacteriologyAmerican Review of Respiratory Disease, 1988
- Comparison of two pretreatment methods for the detection of mycobacteria of BACTEC and Lowenstein-Jensen slantsJournal of Microbiological Methods, 1987